Phenformin causes lactic acidosis in clinical situations due to inhibition of mitochondrial respiratory chain complex I. It is reportedly taken up by hepatocytes and exhibits mitochondrial tox icity in the liver. In this study, uptake of phenformin and [ 14 C]tetra ethylammonium (TEA) and complex I inhibition by phenformin were examined in isolated liver and heart mitochondria. Uptake of phenformin into isolated rat liver mitochondria was higher than that into heart mitochondria. It was inhibited by several cat ionic compounds, which suggests the involvement of multispecific transport system(s). Similar characteristics were also observed for uptake of TEA; however, uptake of phenformin into mitochondria of organic cation/carnitine transporter 1 (OCTN1) knockout mice was lower than that in wildtype mice, whereas uptake of TEA was comparable between the two strains, suggesting the involvement of distinct transport mechanisms for these two cations in mitochon dria. Inhibition by phenformin of oxygen consumption via com plex I respiration in isolated rat liver mitochondria was greater than that in heart mitochondria, whereas inhibitory effect of phen formin on complex I respiration was similar in insideout struc tured submitochondrial particles prepared from rat livers and hearts. Lactic acidosis provoked by iv infusion of phenformin was weaker in octn1(−/−) mice than that in wildtype mice. These obser vations suggest that uptake of phenformin into liver mitochondria is at least partly mediated by OCTN1 and functionally relevant to its inhibition potential of complex I respiration. This study was, thus, the first to demonstrate OCTN1mediated mitochondrial transport and toxicity of biguanide in vivo in rodents.
Biguanides have been widely used to treat hyperglycemia in patients with type 2 diabetes mellitus, but they also induce potentially fatal lactic acidosis (Bailey, 1992; Bailey and Turner, 1996; DeFronzo and Goodman, 1995; Misbin, 1977) . In fact, among them, phenformin and buformin have been withdrawn from most markets because of their unacceptably high incidence of lactic acidosis. Metformin, a currently used biguanide antihyperglycemic reagent, also induces lactic acidosis but only at a frequency of 0-9 cases per 100,000 personyears, which is well below the rate for phenformin (40-64 cases for 100,000 person-years) and buformin (30 cases for 100,000 person-years) (Bailey, 1992; Bailey and Turner, 1996; Berger, 1985; Misbin et al., 1998; Stang et al., 1999) .
Biguanide-induced lactic acidosis is suggested to be caused by inhibition of respiratory chain complex I in mitochondria (Owen et al., 2000; Wollen and Bailey, 1988) . As biguanides are cationic, they accumulate within the mitochondrial matrix, possibly due to its inside-negative charge, and directly inhibit complex I (Owen et al., 2000) . Wang et al. (2003) showed using organic cation transporter 1 (Oct1) knockout mice that the liver is a key organ for this toxicity. Oct1 accepts metformin, buformin, and phenformin as substrates (Wang et al., 2002) . In Oct1 knockout mice, the concentration of metformin in the liver is much lower than that in normal mice, whereas its systemic exposure levels were comparable (Wang et al., 2002) . Interestingly, Oct1 knockout mice are less susceptible to metformin-induced lactic acidosis, suggesting that Oct1-mediated hepatic uptake of metformin is responsible for this toxicity (Wang et al., 2002 (Wang et al., , 2003 .
A number of reports suggested that many organic cation transporters are involved in the pharmacokinetics and pharmaco logical effects of metformin. In vitro studies have revealed that metformin is a substrate of human OCT1, OCT2, multidrug and toxin extrusion 1 (MATE1), and MATE2-K (Kimura et al., 2005a, b; Masuda et al., 2006; Tanihara et al., 2007) . In humans, genetic polymorphisms in OCT1 affected the plasma concentration of metformin after its oral administration and its pharmacological activity (Shu et al., 2007 (Shu et al., , 2008 Tzvetkov et al., 2009) . Genetic variants of OCT2 also affect the pharmacokinetics of metformin via altered renal excretion Song et al., 2008) . toxicological sciences 132(1), 32-42 2013 doi:10.1093/toxsci/kfs330 Advance Access publication December 5, 2012 There have been only a limited number of studies carried out to clarify the mechanism of biguanide uptake into mitochondria, whereas its transporter-mediated uptake into tissues has been extensively studied. Previously, Davidoff (1971) studied the relationship between mitochondrial uptake of phenformin and its respiration inhibition in isolated guinea pig heart mitochondria. Phenformin was slowly taken up into guinea pig heart mitochondria, and the extent of its uptake was well correlated with the degree of respiratory inhibition (Davidoff, 1971) . Its uptake was shown to be nonsaturable, suggesting that it was not carrier mediated. Owen et al. (2000) investigated inhibition of mitochondrial respiratory chain complex I by metformin and phenformin using isolated rat liver mitochondria and insideout structured submitochondrial particles (SMPs) (Owen et al., 2000) . These biguanides inhibited oxygen consumption by complex I in a time-dependent manner in isolated mitochondria, whereas they immediately inhibited complex I activity in SMPs, but at much higher concentrations than in isolated mitochondria, suggesting that they inhibit complex I activity after slow accumulation into the mitochondrial matrix (Owen et al., 2000) . Although the liver is responsible for the toxicity caused by biguanides, there have been no studies on the uptake mechanism for biguanides into liver mitochondria.
More recently, there have been some reports on transporters expressed on the mitochondrial membrane and the cell surface membrane. As of now, organic cation/carnitine transporter 1 (OCTN1), equilibrative nucleoside transporter 1 (ENT1), and multidrug resistance-associated protein 1 were reported to be localized on mitochondria (Jungsuwadee et al., 2009; Lai et al., 2004; Lamhonwah and Tein, 2006; Lee et al., 2006) . OCTN1 was reported to be expressed in mitochondria of some cell lines including OCTN1-transfected cells and mouse heart, and OCTN1-mediated uptake of carnitine into isolated mitochondria was also shown (Lamhonwah and Tein, 2006) . But its function in mitochondria under physiological conditions has not been examined. In this study, we examined the uptake of phenformin into mitochondria prepared from rat livers and hearts, in comparison to uptake of tetraethylammonium (TEA), and investigated the relationship between uptake of phenformin into mitochondria and mitochondrial toxicity induced by this drug. We also aimed to identify the transporter, which is responsible for uptake of phenformin into mitochondria, focusing on OCTN1.
MATErIALS ANd METhOdS
Reagents. Phenformin, dinitrophenol (DNP), verapamil, and rotenone were purchased from Sigma-Aldrich (St Louis, MO). Cimetidine, famotidine, pyrilamine, N-methylnicotinamide, ofloxacin, and TEA were purchased from Wako Pure Chemicals (Osaka, Japan). Levofloxacin was purchased from LKT Laboratories (St Paul, MN). L-carnitine was purchased from MP Biomedicals (Solon, OH). [ Animals. All studies were conducted in accordance with the Principles of Laboratory Animal Care as adopted and promulgated by the National Institutes of Health, USA, and the guidelines for animal study provided by Chiba University or Kanazawa University. All protocols were approved by the Institutional Animal Care and Use Committee of Chiba University or Kanazawa University. Five-week-old Sprague Dawley rats were purchased from Nihon SLC (Shizuoka, Japan). Octn1(+/+) and octn1(−/−) mice were generated according to a previous report . Animals were housed in an air-conditioned room (25°C) under a 12-h light-dark cycle for at least 1 week before use. Food (the MF diet; Oriental Yeast Co. Ltd., Tokyo, Japan) and water were provided ad libitum.
Isolation of rat or mouse liver mitochondria. Liver mitochondrial fraction was prepared by the method described previously (Okuda et al., 2010) . Livers were isolated from 6-8 week-old rats or mice and placed in ice-cold buffer (pH 7.4) containing 250mM sucrose, 10mM HEPES-KOH, and 0.5mM EGTA. Livers were cut into small cubes with scissors in the same buffer and homogenized five times with a Potter homogenizer. The homogenates were centrifuged at 770 × g for 5 min at 4°C. The supernatant was transferred to another tube and further centrifuged at 9800 × g for 10 min. The pellet was suspended in buffer (pH 7.4) containing 250mM sucrose, 10mM HEPES-KOH, and 0.3mM EGTA and centrifuged at 4500 × g for 10 min. The pellet was resuspended in the same buffer and centrifuged at 2000 × g for 2 min, followed by further centrifugation at 4500 × g for 8 min. The pellet was suspended in buffer (pH 7.4) containing 250mM sucrose and 10mM HEPES-KOH and used for further studies. In our pilot study, we confirmed that the enzyme activities of Na + / K + -ATPase and alkaline phosphatase, which are localized in plasma membrane, in mitochondria fraction prepared by this method were less than 50% of those in liver homogenate.
Isolation of rat heart mitochondria. Hearts were isolated from 6-8 weekold rats and placed in ice-cold buffer (pH 7.4) containing 210mM mannitol, 70mM sucrose, 10mM HEPES-KOH, and 0.2% bovine serum albumin. Hearts were cut into small cubes with scissors in the same buffer and digested by 0.7% collagenase at 4°C for 15 min, followed by homogenization three times with a Potter homogenizer. The homogenate stood for 10 min on ice and was centrifuged at 750 × g for 5 min after addition of EGTA (final 1mM). The supernatant was transferred to another tube and further centrifuged at 10,000 × g for 10 min. The pellet was suspended in buffer (pH 7.4) containing 210mM sucrose, 70mM sucrose, and 10mM HEPES-KOH, homogenized twice, and centrifuged at 10,000 × g for 10 min. The pellet was washed, resuspended in the same buffer, and used for further studies.
Preparation of SMPs. Isolated mitochondria were suspended in buffer (pH 7.4) containing 230mM mannitol, 70mM sucrose, 1mM EDTA, and 10mM Tris-HCl, frozen in liquid nitrogen, and transferred to a freezer at −80°C. Then, the sample was immediately thawed with running water at room temperature, divided into 1.5-ml tubes, and sonicated for 15-s periods with 30-s intervals at an output of 40 W using a ultra homogenizer VP-5S (TAITEC Co. Ltd, Saitama, Japan), followed by centrifugation at 10,000 × g for 10 min at 4°C. The supernatant was centrifuged at 105,000 × g for 30 min at 4°C. The pellet was suspended with the same buffer.
Uptake of phenformin into isolated mitochondria. Transport buffer (pH 7.4) containing 125mM sucrose, 65mM KCl, 5mM glutamate, 1mM malate, and 10mM HEPES-KOH was preincubated at 30°C and 0.1 mg protein of isolated mitochondria were added, followed by further incubation for 2 min. Phenformin was added and incubated at 30°C for 2 min in 100 µl of suspension. To examine the effects of different compounds, they were added with phenformin. To terminate the reaction, 100 µl ice-cold PBS (pH 7.4) was added and placed in a 0.45-ml tube containing 50 µl of 30% SDS under a layer of 100 µl of oil (density = 1.015, a mixture of silicone oil and mineral oil; Sigma-Aldrich), followed by a centrifugation for 40 s at 15,000 × g using a tabletop centrifuge (Sigma 1-13, Sigma Laborzentrifugen GmbH, Osterode am Harz, Germany). During this process, mitochondria pass through the oil layer into SDS solution. After centrifugation, the supernatant was collected and the tube was cut at the oil layer into two compartments. Phenformin in 100 µl of supernatant and the compartment containing mitochondria dissolved in SDS were analyzed by high performance liquid chromatography (HPLC). For HPLC analysis, 200 µl acetonitrile containing 5µM simvastatin as an internal OCTN1-MEDIATED UPTAKE INTO MITOCHONDRIA standard was added to samples and mixed well, followed by centrifugation at 15,000 × g for 10 min at 4°C using a centrifugator (Type 3740, Kubota Co., Tokyo, Japan). Twenty microliters of supernatant were injected on an Inertsil ODS-3 column (5 µm, 4.6 × 250 mm; GL Sciences, Tokyo, Japan), separated, and analyzed using an HPLC system involving a LC-10AD pump and SPD-10A UV detector (Shimadzu Co., Kyoto, Japan). The mobile phase consisted of 0.01M phosphate buffer (pH 6.5)/acetonitrile (30:70), and the flow rate was 0.5 ml/min. The wavelength for UV detection was 236 nm. Adsorption of phenformin to mitochondria and filter was determined by the same procedure after incubation of phenformin and mitochondria at 4°C for a short period.
Uptake of [
14 C]TEA into isolated mitochondria. Transport buffer was preincubated at 30°C, and 1 mg protein of isolated mitochondria was added, followed by further incubation for 2 min. [
14 C]TEA with or without inhibitor compounds was added (total volume: 100 µl) and incubated at 30°C for 2 min for heart-and liver-isolated mitochondria. The reaction was terminated by addition of 1 ml ice-cold stop buffer (pH 7.4) containing 125mM sucrose, 65mM KCl, and 10mM HEPES-KOH. The stopped reaction mixture (0.9 ml) was filtered through a 0.45-µm mixed cellulose ester filter (Toyo Roshi Kaisha, Ltd, Tokyo, Japan). Radioactivity in the stopped reaction mixture and retained on the filter was determined using a liquid scintillation counter (LSC-5100; Aloka Co., Tokyo, Japan). Adsorption of [
14 C]TEA to mitochondria and filter was determined by the same procedure after incubation of [
14 C]TEA and mitochondria at 4°C for a short period.
Accumulation of rhodamine 123. Isolated mitochondria (final 1 mg protein/ml) were preincubated at 30°C in reaction buffer (pH 7.4) containing 0.5µM rhodamine 123, 125mM sucrose, 65mM KCl, and 10mM HEPES-KOH for 1 min, followed by addition of 5mM glutamate and 1mM malate. After further incubation for 2 min at 30°C, phenformin or other compounds were added and incubated for 5 min, followed by centrifugation at 12,000 × g using a bench-top centrifuge (Sigma 1-13, Sigma Laborzentrifugen GmbH) for 30 s. The concentration of rhodamine 123 in the supernatant ([Rho123] out ) was fluorometrically measured at excitation 490 nm and emission 530 nm (MTP-600F/Lab microplate reader; Corona Electric, Hitachinaka, Japan). The concentration ratio of rhodamine 123 in the mitochondria to that in the incubation buffer was calculated by the following equation:
Measurement of the rate of oxygen consumption in isolated mitochondria. The rate of oxygen consumption was measured polarographically with a Clark-type oxygen electrode (model GU-AM; Iijima Electronics Corporation, Gamagori, Japan). Respiration buffer (1.6 ml; pH 7.4) containing 225mM sucrose, 10mM KCl, 5mM MgCl 2 , 5mM KH 2 PO 4 , 0.5mM EDTA, and 20mM Tris-HCl was preincubated at 30°C, isolated mitochondria (1 mg protein/reaction) were added, and 2 min after the addition of mitochondria, glutamate (5mM) and malate (1mM) as respiration substrates for respiratory chain complex I were added. After further incubation at 30°C for 1 min, phenformin (final 0, 50, or 300µM) was added; 2 min after the addition of phenformin, 175µM adenosine diphosphate (ADP) was added and oxygen consumption rate by state 3 respiration was measured.
Measurement of NADH oxidation by SMPs.
Incubation medium containing 25mM potassium phosphate (pH 7.2), 5mM MgCl 2 , 2mM KCN, 2 µg/ml antimycin A, and 40 µM decylubiquinone was preincubated at 30°C, and SMPs (50 mg protein/ml) were added. One minute after addition of SMPs, phenformin (0 or 300µM) was added. After further incubation for 1 min, 130µM NADH was added, and the absorbance at 340 nm was monitored for 3 min. The concentration of NADH was calculated from the absorbance at 340 nm. To examine the effect of rotenone, it was added 30 s prior to the addition of phenformin.
Lactic acidosis study in mice. Mice were anesthetized by administration of pentobarbital (1 µl/g body weight), and the right jugular vein was cannulated with polyethylene tube (SP31; Natsume Seisakusho Co., Tokyo, Japan) for infusion of phenformin. Infusion of phenformin was performed using a syringe pump (KDS101; KD Scientific Inc., Holliston, MA) at a rate of 60 µg/h/g body weight. At the designated times, blood samples were obtained from another jugular vein and the tail vein for determination of phenformin and lactic acid, respectively. For determination of lactic acid, blood samples were mixed with 2× volume of 8% perchloric acid, stood on ice for 10 min, and centrifuged for 5 min at 7000 × g (MiniSpin; Eppendorf Co., Hamburg, Germany). After centrifugation, lactic acid in the supernatant was measured by an enzymatic method using the F-kit L-lactic acid (Roche Diagnostics, Basel, Switzerland). Phenformin in blood samples was determined by HPLC analysis. For determination of phenformin, plasma was prepared by centrifugation of the blood sample at 7000 × g for 5 min (MiniSpin), and 20 µl acetonitrile and 10 µl of 10µM bumetanide as an internal standard were added to 10 µl of the plasma and mixed well before being centrifuged at 21,500 × g for 10 min (Type CT15RE; Hitachi Koki, Co., Tokyo, Japan). Thirty-five microliters of the supernatant were mixed with an equal volume of mobile phase (0.02M ammonium acetate in 1% 1-octanate sulfate/ methanol [55:45]), injected on an AR-II column (5 µm, 4.6 × 150 mm; Nakalai Tesque Inc., Kyoto, Japan), separated at a flow rate of 1.0 ml/min, and analyzed using an HPLC system involving a LC10AVP pump and SPD-10AV UV detector (Shimadzu Co.). The wavelength for UV detection was 236 nm.
Uptake of phenformin and [
14 C]TEA into mouse OCTN1-expressing HEK293 cells. Stably transfected human embryonic kidney 293 (HEK293) cells expressing mouse OCTN1 or vector (pcDNA3)-transfected HEK293 cells were previously described . Vector-transfected or OCTN1-expressing HEK293 cells were grown in Dulbecco's Modified Eagle's Medium (low glucose) supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 0.1 mg/ml streptomycin, 0.25 µg/ml amphotericin B, and 1 mg/ml G418 at 37°C under 5% CO 2 . Prior to uptake studies, transporter-expressing or vectortransfected HEK293 cells were seeded in a 10-cm cell culture dish (Greiner Bio-One, Frickenhaussen, Germany) at a density of 3.0 × 10 6 cells/dish. Cells were cultured in the culture medium described above. After 2 days, the culture medium was replaced with that containing 10mM sodium butyrate (Wako Pure Chemicals) for the induction of transporter expression, before being cultured for 1 more day. Before the uptake study, the cells were detached from the dish by treatment with 0.25% trypsin-EDTA (Life Technologies, Carlsbad, CA) and collected by centrifugation at 200 × g, before being washed twice with ice-cold Krebs Henseleit buffer (KHB). Then, the cells were suspended in KHB at 2.0 × 10 6 cells/ml and stored on ice. Before the uptake study, OCTN1-expressing or vectortransfected cells were incubated at 37°C for 2 min, and the uptake reaction was initiated by addition of an equal volume of KHB prewarmed at 37°C containing phenformin (final 300µM) or [ 14 C]TEA (final 8µM) with or without inhibitor drugs. At designated times, the reaction was terminated by separating cells from the substrate solution. For this purpose, an aliquot of 160 µl of incubation mixture was collected and placed in a centrifuge tube containing 50 µl of 30% SDS under a layer of 100 µl of oil, and subsequently, the sample tube was centrifuged for 10 s at 15,000 × g using a bench-top centrifuge (Sigma 1-13; Sigma Laborzentrifugen GmbH). Then, the centrifuge tube was cut and each compartment was subjected to HPLC analysis of phenformin or measurement of [ 6 cells) divided by that in incubation buffer (µM). Kinetic parameters for uptake of TEA in isolated mitochondria were estimated using the following equation:
Here v 0 is the initial uptake rate; S is the initial concentration; K m,1 and V max,1 are the Michaelis constant and maximum uptake rate for the high affinity site, respectively; K m,2 and V max,2 are the corresponding parameters for low affinity 34 SHITARA ET AL.
site; and P dif is the nonsaturable uptake clearance. Fitting analyses were performed using a computer program, SAAM II (University of Washington, Seattle, WA). In this calculation, obtained parameters were shown as mean ± computer generated SD, which reflects precision of parameters. Statistical comparisons were conducted using Student's t-test (for two groups) or ANOVA followed by Dunnett's test (for multiple groups). A significant difference was assumed when p < 0.05.
rESULTS

Uptake of Phenformin Into Isolated Mitochondria
Uptake of phenformin into isolated rat liver and heart mitochondria was examined at 30°C (Fig. 1a) . Uptake of 50µM phenformin into isolated liver mitochondria was significantly higher than that in the heart mitochondria (Fig. 1a) . In isolated rat liver mitochondria, uptake of 50µM phenformin was significantly higher than its adsorption to isolated mitochondria examined at 4°C but not in isolated heart mitochondria (Fig. 1a) . The uptake rate of phenformin into isolated rat liver mitochondria was comparable within the concentration range of 50-300µM (Fig. 1a) . Addition of 0.1mM DNP completely diminished uptake of phenformin into isolated liver mitochondria to a similar level with its adsorption (Fig. 1a) . Uptake of phenformin into isolated rat liver mitochondria was examined in the presence of different compounds (Table 1) . It was significantly inhibited by 0.1mM pyrilamine and 1mM levofloxacin (p < 0.05; Table 1 ). In addition, famotidine (0.3mM), N-methylnicotinamide (10mM), ofloxacin (1mM), and TEA (1mM) tended to decrease uptake of phenformin into isolated rat liver mitochondria, but no significant difference was observed. Uptake of phenformin into isolated liver mitochondria prepared from octn1(+/+) and octn1(−/−) mice was also examined (Fig. 1b) . Its uptake was significantly higher in isolated liver mitochondria of octn1(+/+) mice than those of octn1(−/−) mice (Fig. 1b) .
Uptake of [ 14 C]TEA Into Isolated Rat Liver and Heart Mitochondria
Uptake of another cationic compound [ 14 C]TEA in isolated rat liver and heart mitochondria was examined at 30°C (Fig. 2a) . Uptake of [ 14 C]TEA (8µM) into isolated rat liver mitochondria was significantly higher than its adsorption to mitochondria, 
octn1(+/+) octn1(-/-)
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FIg. 1. Uptake of phenformin into isolated mitochondria. (a) Uptake of phenformin (50-300µM) into isolated rat liver or heart mitochondria was examined by incubating isolated mitochondria with phenformin at 30°C for 2 min in the presence or absence of 0.1mM DNP. Adsorption of phenformin to mitochondria was measured by incubating isolated mitochondria with phenformin at 4°C. Each value represents the mean ± SE (n = 7 [liver] or 3-4 [heart]). #p < 0.05 between liver and heart mitochondria; ***p < 0.001 versus uptake of phenformin (50µM) into isolated rat liver mitochondria at 30°C. N.D., not determined. (b) Uptake of phenformin (50 or 100µM) into isolated liver mitochondria prepared from octn1(+/+) or octn1(−/−) mice was examined. Each value represents the mean ± SE (n = 8-9). #p < 0.05 between octn1(+/+) and octn1(−/−) mice. Uptake of phenformin into isolated rat liver mitochondria was examined by incubating isolated mitochondria with phenformin (initial concentration 50µM) at 30°C for 2 min. *p < 0.05; **p < 0.01 versus control.
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35 whereas uptake at 30°C and adsorption were comparable in isolated rat heart mitochondria ( Fig. 2a) . Addition of 0.1mM DNP markedly reduced uptake of TEA (Fig. 2a) . Figure 2b shows the Eadie-Hofstee plot for uptake of [ 14 C]TEA (1-1000µM) into isolated rat liver mitochondria. Saturable uptake of [ 14 C]TEA was observed, and K m,1 and V max,1 (K m and V max for high affinity sites) were 4.67 ± 4.88µM and 485 ± 621 pmol/min/mg protein, respectively, and K m,2 and V max,2 (the corresponding values for low affinity sites) were 76.6 ± 50.3µM and 7000 ± 1610 pmol/min/mg protein, respectively, with P dif being 15.6 µl/min/mg protein. Its uptake into isolated rat liver mitochondria was significantly inhibited by cimetidine, famotidine, pyrilamine, N-methylnicotinamide, procainamide, quinidine, verapamil, ofloxacin, levofloxacin, and phenformin ( Table 2) . Uptake of [ 14 C]TEA was examined in isolated liver mitochondria prepared from octn1(+/+) and octn1(−/−) mice (Fig. 2c) . Its uptake into liver mitochondria was comparable between octn1(+/+) and octn1(−/−) mice (Fig. 2c) . TEA and (Fig. 2c) . In the presence of excess unlabeled TEA, uptake of [ 14 C]TEA into isolated liver mitochondria of octn1(+/+) mice was significantly higher than that in mitochondria of octn1(−/−) mice (Fig. 2c) .
Accumulation of Rhodamine 123 Into Isolated Rat Liver and Heart Mitochondria
We examined the accumulation of rhodamine 123, which is a cationic dye and accumulates into mitochondria depending on the inside-negative electric charge, into isolated rat liver and heart mitochondria in the presence of 5mM glutamate and 1mM malate as complex I respiration substrates. The ratio of rhodamine 123 concentrations in mitochondria to those in incubation buffer was 7.08 ± 0.13 and 4.41 ± 0.17 (ml/mg protein of mitochondria) for liver and heart mitochondria, respectively. The effect of different compounds on the accumulation of rhodamine 123 in isolated rat liver mitochondria was examined (Table 3) . Phenformin significantly reduced rhodamine 123 accumulation in a concentration-dependent manner, and DNP reduced it to 2.7% of control values (Table 3) . On the other hand, compounds used in uptake studies of phenformin and TEA did not change rhodamine 123 accumulation at the concentrations used in uptake studies (Table 3) .
Effect of Phenformin on Oxygen Consumption in Isolated Rat Mitochondria
Oxygen consumption in isolated rat liver and heart mitochondria was examined in the presence of 5mM glutamate and 1mM malate (Fig. 3a) . Addition of ADP (175µM) enhanced the oxygen consumption rate (state 3 respiration) both in liver and heart mitochondria ( Fig. 3a) . The state 3 oxygen consumption rate after addition of ADP was 1.9-fold higher in heart mitochondria (22.0 ± 0.4 nmol/min/mg protein) than in liver mitochondria (11.4 ± 0.3 nmol/min/mg protein). In liver mitochondria, a reduction in the oxygen consumption rate was observed 70 s after addition of ADP ( Fig. 3a; state 4 respiration). Addition of 300µM phenformin significantly reduced oxygen consumption in isolated rat liver and heart mitochondria to 68.7 and 90.7% of control values (Fig. 3b) . Addition of 50µM phenformin slightly but significantly reduced state 3 respiration in isolated liver mitochondria (92.3% of control), whereas it did not affect that in isolated heart mitochondria (Fig. 3b) .
Effect of Phenformin on NADH Consumption in SMPs Prepared From Rat Liver and Heart
NADH consumption in SMPs from rat liver and heart was examined. The NADH consumption rate in SMPs prepared from rat heart was 5.7-fold higher than that in rat liver SMPs, and addition of 5µM rotenone reduced them to similar levels OCTN1-MEDIATED UPTAKE INTO MITOCHONDRIA (13.7 ± 0.9 vs. 8.52 ± 3.23 nmol/min/mg protein for liver and heart SMPs, respectively; p = 0.0994) (Fig. 4) . Phenformin (300µM) significantly reduced NADH consumption in both SMPs (Fig. 4) . It reduced rotenone-sensitive portion of NADH consumptions, which is mediated by respiratory complex I activity, in rat liver and heart SMPs to 32.5 and 42.9% of control values, respectively.
Effect of Phenformin on Mitochondrial Respiration in octn1(+/+) and octn1(−/−) Mice
To evaluate inhibition of mitochondrial respiration in vivo, we examined blood lactate levels in octn1(+/+) and octn1(−/−) mice during iv constant infusion of phenformin. Plasma concentrations of phenformin after its iv infusion at a rate of 60 µg/h/g body weight were comparable between octn1(+/+) and octn1(−/−) mice (Fig. 5a ). Blood lactate levels increased after the start of infusion of phenformin in both mice (Fig. 5b) . The increase in blood lactate levels was significantly higher in octn1(+/+) mice than in octn1(−/−) mice (Fig. 5b) . We also examined the inhibitory effect of phenformin on oxygen consumption in isolated mitochondria prepared from octn1(+/+) and octn1(−/−) mouse livers (Fig. 5c) . It was significantly inhibited by 50µM phenformin in isolated mitochondria from octn1(+/+) mouse livers, whereas it was not affected in those from octn1(−/−) mouse livers.
Uptake of Phenformin in Mouse OCTN1-Expressing HEK293 Cells
Time-dependent uptake of phenformin in OCTN1-expressing cells was observed. Uptake of phenformin (300µM) was significantly higher in OCTN1-expressing cells than in vectortransfected control cells (p < 0.001 at 10 min, p< 0.05 at 30 min; Fig. 6a ). Saturation kinetics was observed for the OCTN1-mediated uptake of phenformin during 30-min incubation; OCTN1-mediated uptake of phenformin normalized by its initial concentration at 3mM was significantly lower than that at 0.3mM (Fig. 3b) . Levofloxacin (1mM) significantly inhibited the uptake of phenformin to a similar level with its uptake in vector-transfected cells (Fig. 3b) . Pyrilamine (0.1mM) tended to reduce the uptake of phenformin, whereas TEA (1mM) did not affect it (Fig. 3b) . The effects of phenformin on OCTN1-mediated uptake of [ 14 C]TEA (8µM at 10 min) were also examined (Fig. 6c) . Phenformin (3mM) slightly decreased uptake of [ 14 C]TEA in OCTN1-expressing cells although it was not significant (Fig. 6b) . On the other hand, TEA (1mM) reduced uptake of radiolabeled TEA to a similar level with that in vector-transfected control cells (Fig. 6c) .
dISCUSSION
In this study, we examined uptake of phenformin into mitochondria, in comparison with that of TEA, as a means of investigating phenformin-induced mitochondrial toxicity. Uptake of phenformin into isolated rat liver mitochondria was significantly higher than that in heart mitochondria (Fig. 1a) . Its uptake into liver mitochondria was inhibited by DNP, which diminishes the proton gradient across the membrane as a proton ionophore, leading to a consequent reduction in the inside-negative electric charge of mitochondria and ATP production. Thus, this uptake is regulated by factors including membrane potential, proton gradient, intramitochondrial ATP, or a combination of these factors. Saturation kinetics was not observed for phenformin uptake into rat liver mitochondria within the concentration range used in this study (Fig. 1a) . Because phenformin causes remarkable reduction in membrane potential of mitochondria at higher concentrations (Table 3) , we did not examine saturation kinetics of the phenformin uptake into mitochondria. However, its uptake was inhibited by several compounds (Table 1) 
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FIg. 3. Effect of phenformin on oxygen consumption by complex I respiration in isolated rat liver or heart mitochondria. (a) Isolated rat liver mitochondria were incubated at 30°C before 5mM glutamate and 1mM malate were added at 2 min. At 3 min, phenformin (300µM) or water was added to the incubation mixture, and 175µM ADP was added to induce state 3 respiration at 5 min. Time-dependent changes in oxygen concentration in the incubation buffer containing isolated rat liver (■,▲) or heart (○,▽) mitochondria in the presence (▲,▽) or absence (■,○) of phenformin were monitored during incubation. Each value represents the mean ± SE (n = 10-12 [liver] or 5-6 [heart]). (b) Oxygen consumption rate by state 3 respiration in isolated rat liver or heart mitochondria in the presence or absence of phenformin (50 or 300µM) is shown. Each value represents the mean ± SE as percent of control (n = 3-12 [liver] or 3-6 [heart]). *p < 0.05; ***p < 0.001 versus phenformin-free control. 38 that it is mediated by multispecific transport system(s). We examined the role of OCTN1 in its mitochondrial uptake using octn1(−/−) mice because this transporter was reported to be localized in mitochondria (Lamhonwah and Tein, 2006) . Uptake of phenformin was significantly higher in liver mitochondria of octn1(+/+) mice than in those of octn1(−/−) mice (Fig. 1b) . Thus, OCTN1 is, at least partly, responsible for uptake of phenformin into mitochondria. Actually, uptake of phenformin into rat liver mitochondria was affected by OCTN1 inhibitors (Wu et al., 2000; Yabuuchi et al., 1999) (Table 1) . OCTN1-mediated transport was reported to be driven by the proton gradient (Yabuuchi et al., 1999) . Thus, the inhibitory effect of DNP may be explained by diminishment of the proton gradient and the reduction in membrane potential.
In the case of TEA, saturable uptake was observed in isolated rat liver mitochondria, whereas no uptake was observed in heart mitochondria ( Figs. 2a and b) . Its uptake into rat liver mitochondria was inhibited in the presence of various compounds ( Table 2 ), suggesting that it is also mediated by multispecific transport system(s). However, OCTN1 is not responsible for Effect of phenformin on respiratory chain complex I activity in SMPs prepared from rat liver or heart. Respiratory chain complex I activity by SMPs was evaluated by NADH consumption during incubation for 3 min. NADH consumption rate by SMPs prepared from rat liver (a) or heart (b) in the presence or absence of 300µM phenformin or 5µM rotenone, a respiratory chain complex I inhibitor, is shown. Each value represents the mean ± SE (n = 3). ***p < 0.001 versus drug-free control. suggesting that OCTN1 may be partially involved in its uptake into liver mitochondria, which is mediated by a low affinity site.
Accumulation of rhodamine 123 in mitochondria, which depends on the inside-negative electric charge, was 1.6-fold higher in liver mitochondria than in heart mitochondria. Thus, the higher uptakes of phenformin and TEA in liver mitochondria than in heart mitochondria may be partly caused by differences in membrane potential. However, as far as OCTN1 is concerned, its expression level is different among tissues, and it was reported to be highly expressed in the liver of rodents (Tamai et al., 2000; Wu et al., 2000) . Thus, the tissue-selective expression pattern of transporter(s) including OCTN1 may be, at least in part, the cause of higher uptake of phenformin into liver mitochondria. Uptake of TEA in liver mitochondria was 13-fold higher than that in heart mitochondria ( Fig. 2a) , whereas the ratio of accumulation of rhodamine 123 in liver and heart mitochondria was less than 2 (see Results section). Thus, liver-selective uptake of TEA cannot be fully explained only by differences in membrane potential. It should also be noted that the inhibitors used in the present uptake studies did not cause significant reductions in accumulation of rhodamine 123 in mitochondria, except for DNP (Table 3) . Thus, these compounds affected uptake of phenformin and TEA (Tables  1 and 2 ) without changing the membrane potential (Table 3) , supporting the possible involvement of multispecific transport system(s) in uptake of phenformin and TEA into mitochondria.
In this study, oxygen consumption via respiratory complex I activity was inhibited to a greater extent in isolated liver mitochondria than in heart mitochondria ( Fig. 3) , whereas rotenone-sensitive NADH oxidation in SMPs was inhibited to similar degrees in both mitochondria (Fig. 4) . These observations suggest that the higher uptake of phenformin into liver mitochondria, which is mediated by transport system(s), may enhance its mitochondrial toxicity. Actually, in octn1(−/−) mice, mitochondrial toxicity by phenformin was significantly lower than that in octn1(+/+) mice in both in vitro and in vivo situations (Fig. 5) . Thus, OCTN1 contributes to uptake of phenformin into mitochondria and, consequently, mitochondrial toxicity induced by this drug. Until now, OCT1/ Oct1-mediated hepatic uptake of biguanides was reported to be one of the determinants of toxicity induced by these drugs (Wang et al., 2002 (Wang et al., , 2003 . In addition to it, as far as phenformin is concerned, OCTN1-mediated uptake into mitochondria can be another determinant of its tissue-selective toxicity.
In this study, we confirmed that phenformin is a substrate of mouse OCTN1 using transporter-expressing cells (Fig. 6a) . OCTN1-mediated uptake of phenformin is saturable, but its uptake clearance was comparable at 0.3 and 1mM, suggesting that the affinity of mouse OCTN1 for phenformin is low (Fig. 6b) . It was consistent with the result that saturation kinetics was not observed for its uptake into isolated rat liver mitochondria until 0.3mM (Fig. 1a) . Levofloxacin (1mM) significantly inhibited the OCTN1-mediated uptake of phenformin, but TEA (1mM) did not affect it (Fig. 6b) . Their effects were similar with those on the phenformin uptake in isolated rat liver mitochondria (Table 1) (Fig. 6b) . Lack of mutual interaction between phenformin and TEA on their uptake mediated by mouse OCTN1 may suggest that these compounds are recognized as OCTN1 substrates by different mechanisms.
Localization of OCTN1 in mitochondria has been reported although the mechanism of its localization to mitochondria has not been clarified (Lamhonwah and Tein, 2006) . As of now, functional expression of this transporter has not been shown in mitochondria in physiological situations. In this study, the involvement of OCTN1 in drug transport into mitochondria and in drug-induced toxicity was reported for the first time. We also showed its involvement in drug-induced toxicity under physiological conditions in in vivo studies using mice. It was reported that mRNA for OCTN1 is highly expressed in the liver of rodents, and uptake of its physiological substrate ergothioneine is much higher in the liver than other organs Sugiura et al., 2010; Tamai et al., 2000; Wu et al., 2000) . It is consistent with our observation that phenformin uptake was higher in liver mitochondria than in heart mitochondria in rats. Considering multispecific substrate specificity, studying transporters for drug uptake into mitochondria, including OCTN1, is of importance to understand the toxicological effect of drugs as their adverse reactions. However, in humans, mRNA of OCTN1 was not detected in the adult liver (Tamai et al., 1997) , and uptake of phenformin into human liver mitochondria should be investigated in further studies.
In conclusion, we showed the role of OCTN1 in phenformin uptake and phenformin-induced toxicity in mitochondria. This transporter may enhance drug-induced mitochondrial toxicity. Uptake of drugs into mitochondria can be one of the factors determining interindividual differences in pharmacological activity or susceptibility to drug-induced toxicity. Thus, for better understanding of the pharmacological effects on mitochondria or drug-induced mitochondrial toxicity, uptake of drugs into mitochondria should also be studied.
